Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol
- PMID: 1159080
- PMCID: PMC301915
- DOI: 10.1172/JCI108137
Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol
Abstract
The present study determined the effects of 1,25-dihydroxycholecalciferol on serum immunoactive parathyroid hormone and on parathyroid hormone secretion in vitro. Rats injected i.p. with 1,25-dihydroxycholecalciferol, 130 pmol (2 U)/140 g body wt, which is probably a physiologic dose, had a significant 43% decrease in serum immunoreactive parathyroid hormone at 4 h. In addition, this dose of 1,25-dihydroxycholecalciferol inhibited the serum immunoreactive parathyroid hormone response to hypocalcemia induced by phosphate injection. Because the increment in serum immunoreactive parathyroid hormone was less but the decrement in serum calcium more in phosphate plus 1,25-dihydroxycholecalciferol-treated than in phosphate plus vehicle-treated rats, the impaired serum immunoreactive parathyroid hormone response to 1,25-dihydroxycholecalciferol could not be attributed to the change in serum calcium. In studies of parathyroid hormone secretion from bovine parathyroid tissue in vitro, the concentration of 1,25-dihydroxycholecalciferol used for most experiments was 1nM, which is in the range found in rat serum. 1,25-Dihydroxycholecalciferol at 1 or 100 nM significantly inhibited parathyroid hormone secretion when medium calcium concentration was normal (1.5 mM), high (3.0 mM), and low (1.0 mM). Maximum inhibition ranged from 19 to 74%; inhibition was generally seen after 2 h of incubation; and inhibition was sustained or progressive thereafter. Vitamin A, 0.1 muM, caused a marked stimulation of parathyroid hormone secretion. 1,25-Dihydroxycholecalciferol at 1 nM markedly reduced (44%) the effect of vitamin A to stimulate parathyroid hormone secretion. This effect of 1,25-dihydroxycholecalciferol was maximal at 1 h and persisted thereafter. Another steroid, hydrocortisone, 10 muM, did not inhibit parathyroid hormone secretion, suggesting that the 1,25-dihydroxycholecalciferol effect was not a nonspecific inhibitory effect on parathyroid cells. Because other workers have shown that parathyroid hormone directly stimulates 1,25-dihydroxycholecalciferol secretion, our results are consistent with the concept that there is a feedback loop where parathyroid hormone directly stimulates secretion of 1,25-dihydroxycholecalciferol, which in turn directly inhibits secretion of parathyroid hormone.
Similar articles
-
Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog.J Clin Invest. 1978 May;61(5):1375-83. doi: 10.1172/JCI109055. J Clin Invest. 1978. PMID: 659599 Free PMC article.
-
Vitamin D metabolites do not alter parathyroid hormone secretion acutely.Bone Miner. 1986 Dec;1(6):495-505. Bone Miner. 1986. PMID: 3509783
-
The effect of 1,25-dihydroxycholecalciferol on the parathyroid hormone secretion of porcine parathyroid glands and human parathyroid adenomas in vitro.Acta Endocrinol (Copenh). 1977 Nov;86(3):533-8. doi: 10.1530/acta.0.0860533. Acta Endocrinol (Copenh). 1977. PMID: 579021
-
Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism.Clin J Am Soc Nephrol. 2007 Nov;2(6):1283-305. doi: 10.2215/CJN.01520407. Epub 2007 Oct 17. Clin J Am Soc Nephrol. 2007. PMID: 17942777 Review.
-
Hypocalcemia. Differential diagnosis and mechanisms.Arch Intern Med. 1979 Oct;139(10):1166-71. doi: 10.1001/archinte.139.10.1166. Arch Intern Med. 1979. PMID: 226022 Review.
Cited by
-
The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).Endocrine. 2015 Sep;50(1):12-26. doi: 10.1007/s12020-015-0606-x. Epub 2015 May 1. Endocrine. 2015. PMID: 25931412 Review.
-
Studies in a patient with tumor-induced hypophosphatemic osteomalacia.Calcif Tissue Int. 1986 Jun;38(6):358-62. doi: 10.1007/BF02555750. Calcif Tissue Int. 1986. PMID: 3089559
-
Cytoplasmic and nuclear binding components for 1alpha25-dihydroxyvitamin D3 in chick parathyroid glands.Proc Natl Acad Sci U S A. 1975 Dec;72(12):4871-5. doi: 10.1073/pnas.72.12.4871. Proc Natl Acad Sci U S A. 1975. PMID: 1061076 Free PMC article.
-
Autoradiographic studies with 3H 1,25 (OH)2 vitamin D2 and 3H 25 (OH) vitamin D3 in rat parathyroid glands.Cell Tissue Res. 1981;221(2):333-8. doi: 10.1007/BF00216737. Cell Tissue Res. 1981. PMID: 6895484
-
Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog.J Clin Invest. 1977 Aug;60(2):332-41. doi: 10.1172/JCI108781. J Clin Invest. 1977. PMID: 874095 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources